Your browser doesn't support javascript.
loading
Re: Denosumab for patients with persistent or relapsed hypercalcemia of malignancy despite recent bisphosphonate treatment.
Tsuda, Moe; Ishiguro, Hiroshi; Yano, Ikuko; Toi, Masakazu.
Affiliation
  • Tsuda M; Affiliation of authors: Department of Breast Surgery (MTs, MTo) and Outpatient Oncology Unit (HI), Kyoto University Hospital, Kyoto, Japan; Graduate School of Pharmaceutical Sciences (IY), Kyoto University, Kyoto, Japan.
  • Ishiguro H; Affiliation of authors: Department of Breast Surgery (MTs, MTo) and Outpatient Oncology Unit (HI), Kyoto University Hospital, Kyoto, Japan; Graduate School of Pharmaceutical Sciences (IY), Kyoto University, Kyoto, Japan. hishimd@kuhp.kyoto-u.ac.jp.
  • Yano I; Affiliation of authors: Department of Breast Surgery (MTs, MTo) and Outpatient Oncology Unit (HI), Kyoto University Hospital, Kyoto, Japan; Graduate School of Pharmaceutical Sciences (IY), Kyoto University, Kyoto, Japan.
  • Toi M; Affiliation of authors: Department of Breast Surgery (MTs, MTo) and Outpatient Oncology Unit (HI), Kyoto University Hospital, Kyoto, Japan; Graduate School of Pharmaceutical Sciences (IY), Kyoto University, Kyoto, Japan.
J Natl Cancer Inst ; 106(7)2014 Jul.
Article in En | MEDLINE | ID: mdl-24906398
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bone Neoplasms / Diphosphonates / Bone Density Conservation Agents / Antibodies, Monoclonal, Humanized / Hypercalcemia Limits: Female / Humans / Male Language: En Journal: J Natl Cancer Inst Year: 2014 Type: Article Affiliation country: Japan
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bone Neoplasms / Diphosphonates / Bone Density Conservation Agents / Antibodies, Monoclonal, Humanized / Hypercalcemia Limits: Female / Humans / Male Language: En Journal: J Natl Cancer Inst Year: 2014 Type: Article Affiliation country: Japan